STE
STERIS plc
Price Chart
Latest Quote
$202.61
+3.21 (+1.61%)
Current Price
| Previous Close | $199.40 |
| Open | $199.34 |
| Day High | $203.04 |
| Day Low | $199.34 |
| Volume | 997,452 |
Stock Information
| Quarterly Dividend / Yield | $2.52 / 1.22% |
| Shares Outstanding | 97.46M |
| Quarterly Dividend Yield | 1.22% |
| Quarterly Dividend | $2.52 |
| Total Debt | $2.09B |
| Cash Equivalents | $439.60M |
| Revenue | $5.94B |
| Net Income | $782.30M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $19.75B |
| P/E Ratio | 25.55 |
| EPS (TTM) | $7.93 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $21.82B |
| Sales | $5.94B |
| Income | $782.30M |
| Book/sh | $73.45 |
| Cash/sh | $4.51 |
| Employees | 18K |
Financial Ratios
| Quick Ratio | 1.34 |
| Current Ratio | 2.09 |
| Debt/Eq | 29.00 |
| EPS Growth TTM | 51.20% |
Returns & Margins
| ROA | 6.65% |
| ROE | 11.37% |
| Gross Margin | 44.24% |
| Operating Margin | 20.04% |
| Profit Margin | 13.18% |
Ownership
| Insider Ownership | 0.30% |
| Institutional Ownership | 100.76% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 16.74 |
| PEG | 1.40 |
| P/S | 3.33 |
| P/B | 2.76 |
Analyst Data
| Recommendation | buy |
| Target Price | $256.86 |
Technical Indicators
| SMA20 | $210.12 |
| SMA50 | $214.06 |
| SMA200 | $237.83 |
| RSI | 33.42 |
| ATR | 4.6241 |
| Shares Float | 97.19M |
| Short Float | 2.11% |
| Short Ratio | 2.09 |
| Volatility | 0.92 |
| Rel Volume | 1.89 |
Performance History
| Week | -2.22% |
| Month | -5.23% |
| Quarter | -6.75% |
| 6 Months | -19.48% |
| YTD | -18.52% |
| Year | -13.84% |
| 3 Years | +0.32% |
| 5 Years | +6.77% |
| 10 Years | +232.25% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $202.61 | 1,599,100 |
| 2026-06-17 | $199.40 | 1,132,500 |
| 2026-06-16 | $206.51 | 859,100 |
| 2026-06-15 | $205.93 | 676,100 |
| 2026-06-12 | $207.56 | 628,300 |
| 2026-06-11 | $207.22 | 646,900 |
| 2026-06-10 | $208.10 | 784,800 |
| 2026-06-09 | $212.88 | 858,900 |
| 2026-06-08 | $210.03 | 721,500 |
| 2026-06-05 | $211.72 | 1,132,700 |
| 2026-06-04 | $211.61 | 998,700 |
| 2026-06-03 | $209.57 | 856,600 |
| 2026-06-02 | $209.14 | 600,300 |
| 2026-06-01 | $210.44 | 702,400 |
| 2026-05-29 | $212.10 | 1,087,500 |
| 2026-05-28 | $214.76 | 861,500 |
| 2026-05-27 | $212.24 | 564,000 |
| 2026-05-26 | $215.63 | 682,400 |
| 2026-05-22 | $215.93 | 645,500 |
| 2026-05-21 | $219.02 | 889,500 |
| 2026-05-20 | $215.33 | 856,300 |
| 2026-05-19 | $213.78 | 794,700 |
About STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
đ° Latest News
STERIS (STE): Buy, Sell, or Hold Post Q1 Earnings?
StockStory âĸ 2026-06-19T10:04:58Z
Is STERIS Stock Underperforming the Dow?
Barchart âĸ 2026-06-15T14:02:04Z
Steris (STE) Stock After Q4 Miss And 2027 Outlook What The Valuation Signals Now
Simply Wall St. âĸ 2026-06-12T05:11:30Z
Why Is Steris (STE) Up 1% Since Last Earnings Report?
Zacks âĸ 2026-06-10T15:30:09Z
Are Options Traders Betting on a Big Move in STERIS Stock?
Zacks âĸ 2026-06-09T17:34:00Z
3 Cash-Producing Stocks We Think Twice About
StockStory âĸ 2026-06-08T10:29:50Z
Is STERIS (STE) Fairly Priced After Recent Share Price Weakness?
Simply Wall St. âĸ 2026-06-05T22:11:36Z
2 of Wall Streetâs Favorite Stocks with Solid Fundamentals and 1 That Underwhelm
StockStory âĸ 2026-06-01T12:40:51Z
CBIZ Stock Is Down 60%. Here's What a $21.7 Million Exit Could Mean
Motley Fool âĸ 2026-05-30T17:30:47Z
Are Wall Street Analysts Predicting STERIS Stock Will Climb or Sink?
Barchart âĸ 2026-05-26T14:02:34Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,309,400,000 | $3,056,800,000 | $2,920,500,000 | $2,555,540,000 |
| Cost Of Revenue | $3,309,400,000 | $3,056,800,000 | $2,920,500,000 | $2,555,540,000 |
| Total Revenue | $5,935,900,000 | $5,459,500,000 | $5,138,700,000 | $4,536,266,000 |
| Operating Revenue | $5,935,900,000 | $5,459,500,000 | $5,138,700,000 | $4,536,266,000 |
| Expenses | ||||
| Interest Expense | $60,700,000 | $86,300,000 | $144,400,000 | $110,835,000 |
| Total Expenses | $4,830,000,000 | $4,498,700,000 | $4,276,500,000 | $3,744,680,000 |
| Other Income Expense | $-7,600,000 | $-86,800,000 | $-26,000,000 | $-485,000 |
| Other Non Operating Income Expenses | $-3,500,000 | $7,400,000 | - | - |
| Net Non Operating Interest Income Expense | $-50,900,000 | $-77,900,000 | $-133,400,000 | $-110,835,000 |
| Interest Expense Non Operating | $60,700,000 | $86,300,000 | $144,400,000 | $110,835,000 |
| Operating Expense | $1,520,600,000 | $1,441,900,000 | $1,356,000,000 | $1,189,140,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $782,300,000 | $610,200,000 | $551,500,000 | $557,414,000 |
| Net Interest Income | $-50,900,000 | $-77,900,000 | $-133,400,000 | $-110,835,000 |
| Interest Income | $9,800,000 | $8,400,000 | $11,000,000 | - |
| Normalized Income | $785,373,532 | $682,547,777 | $571,962,000 | $557,810,730 |
| Net Income From Continuing And Discontinued Operation | $782,300,000 | $614,700,000 | $378,300,000 | $107,030,000 |
| Total Operating Income As Reported | $1,101,800,000 | $866,600,000 | $836,100,000 | $791,101,000 |
| Net Income Common Stockholders | $782,300,000 | $614,600,000 | $378,200,000 | $107,030,000 |
| Net Income | $782,300,000 | $614,700,000 | $378,300,000 | $107,030,000 |
| Net Income Including Noncontrolling Interests | $785,100,000 | $616,100,000 | $380,100,000 | $105,813,000 |
| Net Income Discontinuous Operations | $0 | $4,500,000 | $-173,200,000 | $-450,384,000 |
| Net Income Continuous Operations | $785,100,000 | $611,600,000 | $553,300,000 | $556,197,000 |
| Pretax Income | $1,047,300,000 | $796,200,000 | $702,800,000 | $680,266,000 |
| Special Income Charges | $-4,100,000 | $-94,200,000 | $-26,000,000 | $-485,000 |
| Interest Income Non Operating | $9,800,000 | $8,400,000 | $11,000,000 | - |
| Operating Income | $1,105,900,000 | $960,900,000 | $862,200,000 | $791,586,000 |
| Gross Profit | $2,626,500,000 | $2,402,800,000 | $2,218,200,000 | $1,980,726,000 |
| Per Share | ||||
| Diluted EPS | $7.93 | $6.20 | $3.81 | $1.07 |
| Basic EPS | $7.97 | $6.24 | $3.83 | $1.07 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,026,468 | $-21,852,223 | $-5,538,000 | $-88,270 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,598,600,000 | $1,452,900,000 | $1,438,400,000 | $1,344,483,000 |
| Total Unusual Items | $-4,100,000 | $-94,200,000 | $-26,000,000 | $-485,000 |
| Total Unusual Items Excluding Goodwill | $-4,100,000 | $-94,200,000 | $-26,000,000 | $-485,000 |
| Reconciled Depreciation | $486,500,000 | $476,200,000 | $565,200,000 | $552,897,000 |
| EBITDA (Bullshit earnings) | $1,594,500,000 | $1,358,700,000 | $1,412,400,000 | $1,343,998,000 |
| EBIT | $1,108,000,000 | $882,500,000 | $847,200,000 | $791,101,000 |
| Diluted Average Shares | $98,700,000 | $99,069,000 | $99,359,000 | $100,246,000 |
| Basic Average Shares | $98,200,000 | $98,575,000 | $98,787,000 | $99,706,000 |
| Diluted NI Availto Com Stockholders | $782,300,000 | $614,600,000 | $378,200,000 | $107,030,000 |
| Minority Interests | $-2,800,000 | $-1,400,000 | $-1,800,000 | $1,217,000 |
| Tax Provision | $262,200,000 | $184,700,000 | $149,500,000 | $124,069,000 |
| Restructuring And Mergern Acquisition | $4,100,000 | $46,000,000 | $26,000,000 | $485,000 |
| Research And Development | $112,900,000 | $107,600,000 | $103,700,000 | $98,477,000 |
| Selling General And Administration | $1,407,700,000 | $1,334,300,000 | $1,252,300,000 | $1,090,663,000 |
| Gain On Sale Of Business | - | $7,425,000 | $0 | $0 |
| Other Special Charges | - | $48,200,000 | - | - |
| Impairment Of Capital Assets | - | - | - | $490,565,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,368,800,000 | $653,400,000 | $112,170,000 | $121,280,000 |
| Total Assets | $10,737,200,000 | $10,146,800,000 | $11,063,697,000 | $10,821,839,000 |
| Total Non Current Assets | $8,342,700,000 | $8,145,900,000 | $8,194,574,000 | $8,810,397,000 |
| Other Non Current Assets | $211,400,000 | $83,000,000 | $66,199,000 | $1,055,151,000 |
| Goodwill And Other Intangible Assets | $5,814,800,000 | $5,950,000,000 | $6,189,994,000 | $5,955,918,000 |
| Other Intangible Assets | $1,620,000,000 | $1,854,300,000 | $2,119,282,000 | $2,076,699,000 |
| Current Assets | $2,394,600,000 | $2,000,800,000 | $2,869,123,000 | $2,011,442,000 |
| Other Current Assets | $230,400,000 | $203,800,000 | $174,349,000 | $176,107,000 |
| Inventory | $631,800,000 | $581,300,000 | $674,535,000 | $604,410,000 |
| Receivables | $1,092,800,000 | $1,044,000,000 | $1,008,315,000 | $864,988,000 |
| Accounts Receivable | $1,092,800,000 | $1,044,000,000 | $1,008,315,000 | $864,988,000 |
| Allowance For Doubtful Accounts Receivable | $-27,300,000 | $-24,400,000 | $-22,984,000 | $-19,284,000 |
| Gross Accounts Receivable | $1,120,100,000 | $1,068,400,000 | $1,031,299,000 | $884,272,000 |
| Cash Cash Equivalents And Short Term Investments | $439,600,000 | $171,700,000 | $207,020,000 | $208,357,000 |
| Cash And Cash Equivalents | $439,600,000 | $171,700,000 | $207,020,000 | $208,357,000 |
| Assets Held For Sale Current | - | $0 | $804,904,000 | $157,580,000 |
| Prepaid Assets | - | - | - | $179,277,000 |
| Debt | ||||
| Net Debt | $1,492,200,000 | $1,872,000,000 | $2,999,080,000 | $2,870,298,000 |
| Total Debt | $2,087,200,000 | $2,202,500,000 | $3,383,167,000 | $3,248,277,000 |
| Long Term Debt And Capital Lease Obligation | $1,932,500,000 | $2,043,300,000 | $3,265,990,000 | $3,158,212,000 |
| Long Term Debt | $1,812,900,000 | $1,918,700,000 | $3,120,162,000 | $3,018,655,000 |
| Current Debt And Capital Lease Obligation | $154,700,000 | $159,200,000 | $117,177,000 | $90,065,000 |
| Current Debt | $118,900,000 | $125,000,000 | $85,938,000 | $60,000,000 |
| Other Current Borrowings | $118,900,000 | $125,000,000 | $85,938,000 | $60,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,540,000,000 | $3,531,000,000 | $4,748,351,000 | $4,734,667,000 |
| Total Non Current Liabilities Net Minority Interest | $2,395,000,000 | $2,508,800,000 | $3,817,224,000 | $3,872,823,000 |
| Other Non Current Liabilities | $22,000,000 | $12,700,000 | $21,037,000 | $21,197,000 |
| Tradeand Other Payables Non Current | $300,000 | $1,900,000 | $6,508,000 | $10,082,000 |
| Non Current Deferred Liabilities | $390,700,000 | $403,700,000 | $479,688,000 | $617,538,000 |
| Non Current Deferred Taxes Liabilities | $390,700,000 | $403,700,000 | $479,688,000 | $617,538,000 |
| Current Liabilities | $1,145,000,000 | $1,022,200,000 | $931,127,000 | $861,844,000 |
| Other Current Liabilities | $271,500,000 | $238,600,000 | $239,709,000 | $201,364,000 |
| Current Deferred Liabilities | $59,100,000 | $57,500,000 | $70,460,000 | $85,727,000 |
| Payables And Accrued Expenses | $423,600,000 | $358,500,000 | $325,137,000 | $354,357,000 |
| Interest Payable | $6,200,000 | $7,800,000 | $11,109,000 | $9,243,000 |
| Payables | $367,400,000 | $302,300,000 | $265,363,000 | $304,642,000 |
| Total Tax Payable | $28,600,000 | $21,500,000 | $13,640,000 | $40,477,000 |
| Income Tax Payable | $28,600,000 | $21,500,000 | $13,640,000 | $40,477,000 |
| Accounts Payable | $338,800,000 | $280,800,000 | $251,723,000 | $264,165,000 |
| Liabilities Heldfor Sale Non Current | - | - | $0 | $20,936,000 |
| Equity | ||||
| Common Stock Equity | $7,183,600,000 | $6,603,400,000 | $6,302,164,000 | $6,077,198,000 |
| Total Equity Gross Minority Interest | $7,197,200,000 | $6,615,800,000 | $6,315,346,000 | $6,087,172,000 |
| Stockholders Equity | $7,183,600,000 | $6,603,400,000 | $6,302,164,000 | $6,077,198,000 |
| Other Equity Interest | $-100,000 | - | - | - |
| Gains Losses Not Affecting Retained Earnings | $-113,100,000 | $-292,300,000 | $-328,657,000 | $-320,710,000 |
| Other Equity Adjustments | $-113,100,000 | $-292,300,000 | $-328,657,000 | $-320,710,000 |
| Retained Earnings | $3,015,900,000 | $2,475,300,000 | $2,087,645,000 | $1,911,533,000 |
| Other | ||||
| Ordinary Shares Number | $97,800,000 | $98,301,000 | $98,883,000 | $98,629,000 |
| Share Issued | $97,800,000 | $98,301,000 | $98,883,000 | $98,629,000 |
| Tangible Book Value | $1,368,800,000 | $653,400,000 | $112,170,000 | $121,280,000 |
| Invested Capital | $9,115,400,000 | $8,647,100,000 | $9,508,264,000 | $9,155,853,000 |
| Working Capital | $1,249,600,000 | $978,600,000 | $1,937,996,000 | $1,149,598,000 |
| Capital Lease Obligations | $155,400,000 | $158,800,000 | $177,067,000 | $169,622,000 |
| Total Capitalization | $8,996,500,000 | $8,522,100,000 | $9,422,326,000 | $9,095,853,000 |
| Minority Interest | $13,600,000 | $12,400,000 | $13,182,000 | $9,974,000 |
| Capital Stock | $4,280,900,000 | $4,420,400,000 | $4,543,176,000 | $4,486,375,000 |
| Common Stock | $4,280,900,000 | $4,420,400,000 | $4,543,176,000 | $4,486,375,000 |
| Employee Benefits | $10,000,000 | $9,400,000 | $9,207,000 | $10,099,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $8,400,000 | $8,100,000 | $7,886,000 | $8,946,000 |
| Long Term Capital Lease Obligation | $119,600,000 | $124,600,000 | $145,828,000 | $139,557,000 |
| Long Term Provisions | $39,500,000 | $37,800,000 | $34,794,000 | $34,759,000 |
| Current Deferred Revenue | $59,100,000 | $57,500,000 | $70,460,000 | $85,727,000 |
| Current Capital Lease Obligation | $35,800,000 | $34,200,000 | $31,239,000 | $30,065,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $221,100,000 | $192,700,000 | $164,831,000 | $118,463,000 |
| Current Provisions | $15,000,000 | $15,700,000 | $13,813,000 | $11,868,000 |
| Current Accrued Expenses | $56,200,000 | $56,200,000 | $59,774,000 | $49,715,000 |
| Goodwill | $4,194,800,000 | $4,095,700,000 | $4,070,712,000 | $3,879,219,000 |
| Net PPE | $2,316,500,000 | $2,112,900,000 | $1,938,381,000 | $1,799,328,000 |
| Accumulated Depreciation | $-1,944,600,000 | $-1,731,100,000 | $-1,573,947,000 | $-1,414,101,000 |
| Gross PPE | $4,261,100,000 | $3,844,000,000 | $3,512,328,000 | $3,213,429,000 |
| Construction In Progress | $509,500,000 | $512,100,000 | $500,106,000 | $472,206,000 |
| Other Properties | $985,100,000 | $906,200,000 | $865,843,000 | $804,473,000 |
| Machinery Furniture Equipment | $1,750,600,000 | $1,487,500,000 | $1,331,753,000 | $1,200,885,000 |
| Buildings And Improvements | $903,600,000 | $832,100,000 | $724,492,000 | $658,108,000 |
| Land And Improvements | $112,300,000 | $106,100,000 | $90,134,000 | $77,757,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-39,400,000 | $-49,800,000 | $-43,893,000 | $-35,601,000 |
| Other Inventories | $-100,000 | - | - | - |
| Finished Goods | $355,200,000 | $334,900,000 | $374,182,000 | $325,609,000 |
| Work In Process | $90,700,000 | $83,100,000 | $98,304,000 | $93,971,000 |
| Raw Materials | $225,400,000 | $213,100,000 | $245,942,000 | $220,431,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $972,400,000 | $778,000,000 | $613,000,000 | $394,978,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,341,400,000 | $1,148,100,000 | $973,300,000 | $756,947,000 |
| Cash Flow From Continuing Operating Activities | $1,341,200,000 | $1,148,100,000 | $973,000,000 | $756,947,000 |
| Operating Gains Losses | $3,300,000 | $12,100,000 | $25,300,000 | $22,126,000 |
| Investing Activities | ||||
| Capital Expenditure | $-369,000,000 | $-370,100,000 | $-360,300,000 | $-361,969,000 |
| Investing Cash Flow | $-512,500,000 | $388,800,000 | $-887,400,000 | $-383,330,000 |
| Cash Flow From Continuing Investing Activities | $-512,600,000 | $388,800,000 | $-887,300,000 | $-383,330,000 |
| Net Other Investing Changes | $100,000 | - | $-100,000 | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-235,500,000 | $-211,300,000 | $-11,800,000 | $-308,565,000 |
| Financing Cash Flow | $-568,200,000 | $-1,572,400,000 | $-85,200,000 | $-498,718,000 |
| Cash Flow From Continuing Financing Activities | $-568,200,000 | $-1,572,400,000 | $-85,200,000 | $-498,718,000 |
| Net Other Financing Charges | $-1,800,000 | $-2,300,000 | $-4,800,000 | $-2,265,000 |
| Cash Dividends Paid | $-241,800,000 | $-219,900,000 | $-200,600,000 | $-183,498,000 |
| Common Stock Dividend Paid | $-241,800,000 | $-219,900,000 | $-200,600,000 | $-183,498,000 |
| Net Common Stock Issuance | $-235,500,000 | $-211,300,000 | $-11,800,000 | $-308,565,000 |
| Other | ||||
| Repayment Of Debt | $-125,000,000 | $-1,164,400,000 | $-60,000,000 | $-247,875,000 |
| Issuance Of Debt | $3,000,000 | - | $181,500,000 | $241,657,000 |
| End Cash Position | $439,600,000 | $171,700,000 | $207,000,000 | $208,357,000 |
| Beginning Cash Position | $171,700,000 | $207,000,000 | $208,400,000 | $348,320,000 |
| Effect Of Exchange Rate Changes | $7,200,000 | $200,000 | $-2,100,000 | $-14,862,000 |
| Changes In Cash | $260,700,000 | $-35,500,000 | $700,000 | $-125,101,000 |
| Proceeds From Stock Option Exercised | $32,900,000 | $25,500,000 | $10,500,000 | $1,828,000 |
| Common Stock Payments | $-235,500,000 | $-211,300,000 | $-11,800,000 | $-308,565,000 |
| Net Issuance Payments Of Debt | $-122,000,000 | $-1,164,400,000 | $121,500,000 | $-6,218,000 |
| Net Long Term Debt Issuance | $-122,000,000 | $-1,164,400,000 | $121,500,000 | $-6,218,000 |
| Long Term Debt Payments | $-125,000,000 | $-1,164,400,000 | $-60,000,000 | $-247,875,000 |
| Long Term Debt Issuance | $3,000,000 | - | $181,500,000 | $241,657,000 |
| Net Investment Purchase And Sale | $-134,000,000 | $-10,800,000 | $2,400,000 | $0 |
| Sale Of Investment | $0 | $0 | $3,900,000 | $0 |
| Purchase Of Investment | $-134,000,000 | $-10,800,000 | $-1,500,000 | $0 |
| Net Business Purchase And Sale | $-20,100,000 | $760,500,000 | $-536,800,000 | $-35,948,000 |
| Sale Of Business | $0 | $814,600,000 | $9,500,000 | $6,624,000 |
| Purchase Of Business | $-20,100,000 | $-54,100,000 | $-546,300,000 | $-42,572,000 |
| Net PPE Purchase And Sale | $-358,500,000 | $-360,900,000 | $-352,900,000 | $-347,382,000 |
| Sale Of PPE | $10,500,000 | $9,200,000 | $7,400,000 | $14,587,000 |
| Purchase Of PPE | $-369,000,000 | $-370,100,000 | $-360,300,000 | $-361,969,000 |
| Change In Working Capital | $27,100,000 | $66,500,000 | $-146,200,000 | $-250,023,000 |
| Change In Other Current Assets | $-22,700,000 | $-50,300,000 | $-1,600,000 | $-24,086,000 |
| Change In Payables And Accrued Expense | $98,900,000 | $72,500,000 | $21,000,000 | $31,288,000 |
| Change In Accrued Expense | $47,800,000 | $38,900,000 | $40,000,000 | $-22,054,000 |
| Change In Payable | $51,100,000 | $33,600,000 | $-19,000,000 | $53,342,000 |
| Change In Account Payable | $51,100,000 | $33,600,000 | $-19,000,000 | $53,342,000 |
| Change In Inventory | $-24,000,000 | $73,100,000 | $-37,500,000 | $-123,921,000 |
| Change In Receivables | $-25,100,000 | $-28,800,000 | $-128,100,000 | $-133,304,000 |
| Changes In Account Receivables | $-25,100,000 | $-28,800,000 | $-128,100,000 | $-133,304,000 |
| Other Non Cash Items | $-5,400,000 | $-3,700,000 | $223,800,000 | $-17,469,000 |
| Stock Based Compensation | $61,700,000 | $57,400,000 | $56,500,000 | $38,951,000 |
| Deferred Tax | $-16,900,000 | $-76,500,000 | $-131,400,000 | $-185,913,000 |
| Deferred Income Tax | $-16,900,000 | $-76,500,000 | $-131,400,000 | $-185,913,000 |
| Depreciation Amortization Depletion | $486,500,000 | $476,200,000 | $565,200,000 | $552,897,000 |
| Gain Loss On Sale Of PPE | $3,600,000 | $5,700,000 | $25,000,000 | $22,193,000 |
| Gain Loss On Sale Of Business | $-300,000 | $6,400,000 | $300,000 | $-67,000 |
| Net Income From Continuing Operations | $785,100,000 | $616,100,000 | $380,100,000 | $105,813,000 |
| Interest Paid Supplemental Data | - | $89,401,000 | $142,167,000 | $108,470,000 |
| Income Tax Paid Supplemental Data | - | $273,611,000 | $271,274,000 | $254,661,000 |
| Asset Impairment Charge | - | $0 | $0 | $490,565,000 |
| Net Short Term Debt Issuance | - | - | $181,486,000 | $241,657,000 |
| Gain Loss On Investment Securities | - | - | $-546,000 | - |
| Short Term Debt Payments | - | - | - | - |
Fetched: 2026-06-18